LEASE DATED: AS OF JUNE 9, 2011 BOLTON STREET PARTNERS, LLC, LESSOR AURA BIOSCIENCES, INC, LESSEE 85-95 BOLTON STREET, CAMBRIDGE, MASSACHUSETTSLease Modification • September 20th, 2021 • Aura Biosciences, Inc. • Biological products, (no disgnostic substances) • Massachusetts
THIS LEASE is made as of the 9th day of June, 2011 by and between BOLTON STREET PARTNERS, LLC, a Massachusetts limited liability corporation with a place of business at 126 North Washington Street, Suite 5, Boston, Massachusetts 02114 (“Lessor”), and Aura Biosciences, Inc., a Connecticut corporation, with a principal place of business as of the date hereof at I Kendall Square, Building 600, Ste, B6101, Cambridge, MA 02139 (“Lessee”).
Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Information that was omitted has been noted in this document with a placeholder...Exclusive License and Supply Agreement • September 20th, 2021 • Aura Biosciences, Inc. • Biological products, (no disgnostic substances) • Delaware
This Exclusive License and Supply Agreement (this “Agreement”) is dated January 31, 2014 (“Effective Date”) and is between LI-COR, Inc., a Nebraska corporation with a principal address of 4647 Superior Street, Lincoln, Nebraska 68504 (“LI-COR”), and Aura Biosciences, Inc., a Delaware corporation with a principal address of 85 Bolton Street, Cambridge, MA 02140 (“Aura”). LI-COR and Aura individually referred to herein as a “Party” and collectively as the “Parties”.
Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Information that was omitted has been noted in this document with a placeholder...License Agreement • September 20th, 2021 • Aura Biosciences, Inc. • Biological products, (no disgnostic substances) • Georgia
THIS LICENSE AGREEMENT (the “Agreement”), effective as of July 3, 2019 (the “Effective Date”), is by and between Clearside Biomedical, Inc., a Delaware corporation having a principal place of business at 900 North Point Parkway, Suite 200, Alpharetta, GA 30005 (“Clearside”) and Aura Biosciences, Inc., a Delaware corporation having its principal place of business at 85 Bolton Street, Cambridge, MA 02140 (“Aura”).
Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Information that was omitted has been noted in this document with a placeholder...Patent License Agreement • September 20th, 2021 • Aura Biosciences, Inc. • Biological products, (no disgnostic substances) • District of Columbia
This Patent License Agreement, hereinafter referred to as the “Agreement”, consists of this Cover Page, an attached Agreement, a Signature Page, Appendix A (List of Patent(s) or Patent Application(s)), Appendix B (Fields of Use and Territory), Appendix C (Royalties), Appendix D (Benchmarks and Performance), Appendix E (Commercial Development Plan), Appendix F (Example Royalty Report), and Appendix G (Royalty Payment Options). The Parties to this Agreement are:
